The partnership has provided Living Cell Technologies with $32.3 million to finish development of its Type 1 diabetes treatment and the company hopes to have the product available commercially within three years as reported by DiabeticLive.com. ... Joint Venture Breathes New Life into Type 1 Diabetes Treatment, as Reported by ...
No comments:
Post a Comment